AltStreet
EDGAR Verified
Primary Source · SEC.gov

Bain Capital Life Sciences Fund IV, L.P.

CIK 0001996979Fund Vehicle2024 vintage506(b), 3(c)

Raised

Pre-open

Investors

—

Min Invest

$0

AltStreet Analysis

·

Generated from EDGAR primary sources

Bain Capital Life Sciences Fund IV, L.P. is a Delaware limited partnership filing under Rule 506(b) and Section 3(c) exemptions. This is a pre-open filing with no disclosed capital raised, investor count, or minimum investment. The fund is managed by executive officers Adam Koppel, Jeffrey Schwartz, Ricky Sun, and Andrew Hack, and represents Bain Capital's fourth life sciences-focused vehicle.

This pooled investment fund targets longevity and biotech opportunities, a category typically structured as institutional limited partnerships with high minimum commitments. The 506(b) exemption permits general solicitation restrictions common among established fund managers with existing investor relationships, consistent with traditional life sciences venture capital structures.

Data Flags

generalPre-open filing for a Fund IV vehicle from an established institutional sponsor; suggests anticipated substantial institutional raise not yet commenced

EDGAR Filing Data

Form D — Primary Source

View on SEC.gov
CIK Number0001996979
Entity NameBain Capital Life Sciences Fund IV, L.P.
Exemption506(b), 3(c)
First Sale Date—
Filing DateMarch 28, 2024
Accession Number0001996979-24-000001
Total Amount Sold—
Total Investors—
Minimum Investment$0 (no stated minimum)
Securities TypePooled Investment Fund
State of IncorporationNot specified
Amendment CountOriginal filing only

Related Persons (Form D)

Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.

ADAM KOPPEL

Executive Officer · BOSTON, MA

JEFFREY SCHWARTZ

Executive Officer · BOSTON, MA

RICKY SUN

Executive Officer · BOSTON, MA

ANDREW HACK

Executive Officer · BOSTON, MA

Is this your offering?

Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.

Claim Profile — FreeGet Verified — $2,400/yr

Data Methodology

Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.